Allergic contact dermatitis (ACD) can exist in the setting of other dermatologic conditions. It is known that the treatment of these conditions can cause ACD, increasing both diagnostic and treatment difficulty.
Objective
The aim of this study was to determine the frequency of common dermatologic conditions in the setting of ACD and in specific patient populations.
Methods
A retrospective database study was completed using Truven Health to collect information on patch-tested ACD patients. Demographics and diagnostic information were retrieved. Of those with ACD, the presence of 15 dermatologic diagnoses was investigated. Subanalyses were conducted for each condition, including International Classification of Diseases, 10th Revision code specificity, demographics, and diagnostic information.
Results
A total of 6380 patients (76.83% female) were given a diagnosis of ACD via patch testing. Of those with concomitant disease, those most common include atopic dermatitis (23.98%), urticaria (16.69%), and acne (11.51%). Eight of the concomitant conditions were found to have statistical significance in comparing the average age of ACD diagnosis with the selected diagnoses (α = 0.05).
Conclusions
Common dermatologic diseases can exist concomitantly with ACD, many of which can be treated by compounds that precipitate or worsen preexisting ACD. The average age of the diagnosis varies from concomitant diagnoses, which can contribute to difficulty in ACD diagnosis and treatment.
Get full access to this article
View all access options for this article.
References
1.
MarksJG, MillerJJ. Lookingbill and Marks' Principles of Dermatology. 6th ed. Philadelphia, PA: Elsevier; 2019.
SoJK, HamstraA, CalameA, et al.Another great imitator: allergic contact dermatitis differential diagnosis, clues to diagnosis, histopathology, and treatment. Curr Treat Options Allergy, 2015; 2:333–348.
4.
OwenJL, VakhariaPP, SilverbergJI. The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol, 2018; 19(3):293–302.
5.
Erfurt-BergeC, GeierJ, MahlerV. The current spectrum of contact sensitization in patients with chronic leg ulcers or stasis dermatitis—new data from the information network of departments of dermatology (IVDK). Contact Dermatitis, 2017; 77(3):151–158.
6.
Truven Health MarketScan Research Databases. Commerical Claims and Encounters Medicare Supplemental. Ann Arbor, MI: Truven Health Analytics; 2013.
7.
DekovenJG, WarshawEM, ZugKA, et al.North American Contact Dermatitis Group patch test results: 2015–2016. Dermatitis, 2018; 29(6):297–309.
8.
CorkMJ, RobinsonDA, VasilopoulosY, et al.New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol, 2006; 118(1):3–21.
9.
KantorR, SilverbergJI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol, 2017; 13(1):15–26.
10.
ThyssenJP, KezicS. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol, 2014; 134(4):792–799.
11.
JakasaI, de JonghCM, VerberkMM, et al.Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol, 2006; 155(1):104–109.
12.
Halling-OvergaardAS, KezicS, JakasaI, et al.Skin absorption through atopic dermatitis skin: a systematic review. Br J Dermatol, 2017; 177(1):84–106.
13.
ThyssenJP, McFaddenJP, KimberI. The multiple factors affecting the association between atopic dermatitis and contact sensitization. Allergy, 2014; 69(1):28–36.
14.
JakasaI, VerberkMM, EspositoM, et al.Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol, 2007; 127(1):129–134.
15.
SimonsenAB, JohansenJD, DeleuranM, et al.Contact allergy in children with atopic dermatitis: a systematic review. Br J Dermatol, 2017; 177(2):395–405.
16.
SeoKS, ParkJY, TermanDS, et al.A quantitative real time PCR method to analyze T cell receptor Vβ subgroup expansion by staphylococcal superantigens. J Transl Med, 2010; 8:2.
17.
HuangL, KinbaraM, FunayamaH, et al.The elicitation step of nickel allergy is promoted in mice by microbe-related substances, including some from oral bacteria. Int Immunopharmacol, 2011; 11(11):1916–1924.
18.
TakahashiH, KinbaraM, SatoN, et al.Nickel allergy-promoting effects of microbial or inflammatory substances at the sensitization step in mice. Int Immunopharmacol, 2011; 11(10):1534–1540.
19.
HamannCR, BernardS, HamannD, et al.Is there a risk using hypoallergenic cosmetic pediatric products in the United States?. J Allergy Clin Immunol, 2015; 135(4):1070–1071.
20.
MailholC, Lauwers-CancesV, RanceF, et al.Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy, 2009; 64(5):801–806.
21.
CzarnobilskaE, ObtulowiczK, DygaW, et al.A half of schoolchildren with ‘ISAAC eczema’ are ill with allergic contact dermatitis. J Eur Acad Dermatol Venereol, 2011; 25(9):1104–1107.
22.
HenninoA, BérardF, GuillotI, et al.Pathophysiology of urticaria. Clin Rev Allergy Immunol, 2006; 30(1):3–11.
23.
GauchatJF, HenchozS, MazzeiG, et al.Induction of human IgE synthesis in B cells by mast cells and basophils. Nature, 1993; 365:340–343.
24.
MarkBJ, SlavinRG. Allergic contact dermatitis. Med Clin North Am, 2006; 90:169–185.
25.
IşikS, Caglayan-SözmenS, Anal Ö, et al. Severe neck and face edema in an adolescent—delayed hypersensitivity reaction to hair dye. Pediatr Emerg Care, 2017; 33(6):422–423.
26.
Tukenmez DemirciG, Kivanc AltunayI, AtisG, et al.Allergic contact dermatitis mimicking angioedema due to paraphenylendiamine hypersensitivity: a case report. Cutan Ocul Toxicol, 2012; 31:250–252.
27.
LeeSX, BoontaveeyuwatE, ThaiwatS, et al.Severe allergic contact dermatitis mimicking angioedema caused by propolis used as a traditional remedy. Contact Dermatitis, 2018; 79(3):185–186.
28.
SostedH, JohansenJD, AndersenKE, et al.Severe allergic hair dye reactions in 8 children. Contact Dermatitis, 2006; 54(2):87–91.
29.
ShavitI, HoffmannY, Shachor-MeyouhasY, et al.Delayed hypersensitivity reaction from black henna tattoo manifesting as severe facial swelling. Am J Emerg Med, 2008; 26(4):515.e3–515.e4.
30.
GlatsteinMM, RimonA, DaninoD, et al.Severe allergic contact dermatitis from temporary "black henna" coloring of the hair during religious cultural celebrations: three different cases, same history. Am J Ther, 2016; 23(1):e292–e294.
31.
van GenderenME, CarelsG, LonneeER, et al.Severe facial swelling in a pregnant woman after using hair dye. BMJ Case Rep, 2014; 2014:bcr2013202562.
32.
McFaddenJP, PuangpetP, BasketterDA, et al.Why does allergic contact dermatitis exist?. Br J Dermatol, 2013; 168(4):692–699.
33.
EsserPR, WölfleU, DürrC, et al.Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS One, 2012; 7(7):e41340.
34.
McFaddenJP, DearmanRJ, WhiteJM, et al.The Hapten-Atopy hypothesis II: the ‘cutaneous hapten paradox’. Clin Exp Allergy, 2011; 41(3):327–337.
35.
McFaddenJP, BasketterDA, DearmanRJ, et al.Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease. Clin Dermatol, 2011; 29(3):257–265.
36.
YamasakiK, KanadaK, MacleodDT, et al.TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol, 2011; 131(3):688–697.
37.
HungerRE, SurovyAM, HassanAS, et al.Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol, 2008; 158(4):691–697.
38.
JappeU, SchäferT, SchnuchA, et al.Contact allergy in patients with rosacea: a clinic-based, prospective epidemiological study. J Eur Acad Dermatol Venereol, 2008; 22(10):1208–1214.
39.
FotiC, RomitaP, BorghiA, et al.Contact dermatitis to topical acne drugs: a review of the literature. Dermatol Ther, 2015; 28(5):323–329.
40.
BalatoN, LemboG, CuccurulloFM, et al.Acne and allergic contact dermatitis. Contact Dermatitis, 1996; 34(1):68–69.
FeltonSJ, OrtonD, WilliamsJDL. Benzoyl peroxide in topical acne preparations: an underreported contact allergen?. Dermatitis, 2013; 24(3):146–147.
43.
MinciulloPL, PatafiM, GiannettoL, et al.Allergic contact angioedema to benzoyl peroxide. J Clin Pharm Ther, 2006; 31(4):385–387.
44.
ShwerebC, LowensteinEJ. Delayed type hypersensitivity to benzoyl peroxide. J Drugs Dermatol, 2004; 3(2):197–199.
45.
van JoostT, van UlsenJ, VuzevskiVD, et al.Purpuric contact dermatitis to benzoyl peroxide. J Am Acad Dermatol, 1990; 22(2):359–361.
46.
KostnerL, AnzengruberF, GuillodC, et al.Allergic contact dermatitis. Immunol Allergy Clin North Am, 2017; 37(1):141–152.
47.
BurkemperNM. Contact dermatitis, patch testing, and allergen avoidance. Mo Med, 2015; 112(4):296–300.
48.
McLellandJ, ShusterS, MatthewsJNS. Irritants' increase the response to an allergen in allergic contact dermatitis. Arch Dermatol, 1991; 127(7):1016–1019.
49.
SchwensenJF, MennéT, JohansenJD. The combined diagnosis of allergic and irritant contact dermatitis in a retrospective cohort of 1000 consecutive patients with occupational contact dermatitis. Contact Dermatitis, 2014; 71(6):356–363.
50.
PatelGA, RagiG, LambertWC, et al.Skin disease and old age. In: FillitHM, RockwoodK, WoodhouseK, eds. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 7th ed. Philadelphia, PA: Elsevier; 2010:801–809.
51.
BelsitoDV, DersarkissianRM, ThorbeckeGJ, et al.Reversal by lymphokines of the age-related hyporesponsiveness to contact sensitization and reduced Ia expression on Langerhans cells. Arch Dermatol Res, 1987; (279,suppl):S76–S80.
52.
MangelsdorfHC, FleischerAB, SherertzEF. Patch testing in an aged population without dermatitis: high prevalence of patch test positivity. Am J Contact Dermat, 1996; 7(3):155–157.
53.
WilsonCL, CameronJ, PowellSM, et al.High incidence of contact dermatitis in leg-ulcer patients—implications for management. Clin Exp Dermatol, 1991; 16(4):250–253.
54.
JohansenJD, Aalto-KorteK, AgnerT, et al.European Society of Contact Dermatitis guideline for diagnostic patch testing—recommendations on best practice. Contact Dermatitis, 2015; 73(4):195–221.
55.
BatistaM, GonçaloM. The rash that presents as a red swollen face. Clin Dermatol, 2020; 38(1):63–78.
56.
AndersenMF, LonghurstHJ, RasmussenER, et al.How not to be misled by disorders mimicking angioedema: a review of pseudoangioedema. Int Arch Allergy Immunol, 2016; 169(3):163–170.
57.
FrigasE, ParkMA. Acute urticaria and angioedema: diagnostic and treatment considerations. Am J Clin Dermatol, 2009; 10(4):239–250.
